| http://www.w3.org/ns/prov#value | - Fisher and his colleagues, at the Israel Institute for Biological Research in Ness Ziona, have synthesized and studied series of small molecules in an effort to prove Fisher???s hypothesis that agonists that are highly selective for M1 muscarinic acetylcholine receptors could treat the symptoms of AD, as well as change its course, (see, for example Fisher et al., 2003 and Fisher et al., 1998).
|
